3,961
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges

, , , , &
Pages 1667-1693 | Received 21 Feb 2022, Accepted 08 May 2022, Published online: 14 Jun 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vanessa Martins, Lynsey Fazal, Aram Oganesian, Alpesh Shah, Jessie Stow, Hugh Walton & Nicola Wilsher. (2022) A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies. Xenobiotica 52:8, pages 786-796.
Read now

Articles from other publishers (2)

Antara Chakravarty & Priscilla L. Yang. (2023) Targeted protein degradation as an antiviral approach. Antiviral Research 210, pages 105480.
Crossref
Lan Zhang, Boqin Luo, Yingying Lu & Yi Chen. (2023) Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions. Journal of Medicinal Chemistry 66:2, pages 1112-1136.
Crossref